Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Emi

Showing results (81-90 of 112) with videos related to

Pageof 12
Sort By:
Transplantation Proceedings|February 1, 1995
Evidence that double transfection to xenoendothelial cells using GPI-anchoring complement regulatory factor (decay-accelerating factor and homologous restriction factor 20) gene is useful for the inhibition of human complement-mediated cytolysisS Hayashi, K Isobe, N Emi, et al.
International Journal of Hematology|February 24, 2001
No significant association between HA-1 incompatibility and incidence of acute graft-versus-host disease after HLA-identical sibling bone marrow transplantation in Japanese patientsM Murata, N Emi, N Hirabayashi, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1985
Treatment of plasma cell neoplasm with recombinant leukocyte A interferon and human lymphoblastoid interferonR Ohno, Y Kodera, M Ogura, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|December 1, 1984
[Treatment of hematological malignancies with recombinant leukocyte A interferon (rIFN-alpha A)]R Ohno, Y Kodera, M Ogura, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|November 1, 1995
[Efficacy of early administration of G-CSF after intensive chemotherapy in acute leukemia: a randomized controlled trial. Tokai Infection Study Group on Hematological Disorders]H Takeyama, H Yamada, N Emi, et al.
International Journal of Hematology|May 1, 1999
CD4- and CD56-positive T-cell line, MTA, established from natural killer-like T-cell leukemia/lymphomaN Emi, A Abe, M Kasai, et al.
Leukemia|February 1, 1995
Establishment and characterization of an immature human megakaryoblastic cell line, MEG-A2A Abe, N Emi, H Kato, et al.
British Journal of Haematology|April 1, 1994
Poor response to intensive chemotherapy in de novo acute myeloid leukaemia with trilineage myelodysplasia. Japan Adult Leukaemia Study Group (JALSG)K Kuriyama, M Tomonaga, T Matsuo, et al.
Leukemia|August 1, 1993
Unexpected heterogeneity of PML/RAR alpha fused mRNA detected by nested polymerase chain reaction in acute promyelocytic leukemiaA Matsuoka, K Miyamura, N Emi, et al.
Chemico-Biological Interactions|February 27, 2016
In vitro antiproliferative activity of 2,3-dihydroxy-9,10-anthraquinone induced apoptosis against COLO320 cells through cytochrome c release caspase mediated pathway with PI3K/AKT and COX-2 inhibitionC Balachandran, N Emi, Y Arun, et al.
Pageof 12

Showing results (81-90 of 112) with videos related to

Sort By:
Pageof 12
Transplantation Proceedings|February 1, 1995
Evidence that double transfection to xenoendothelial cells using GPI-anchoring complement regulatory factor (decay-accelerating factor and homologous restriction factor 20) gene is useful for the inhibition of human complement-mediated cytolysisS Hayashi, K Isobe, N Emi, et al.
International Journal of Hematology|February 24, 2001
No significant association between HA-1 incompatibility and incidence of acute graft-versus-host disease after HLA-identical sibling bone marrow transplantation in Japanese patientsM Murata, N Emi, N Hirabayashi, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1985
Treatment of plasma cell neoplasm with recombinant leukocyte A interferon and human lymphoblastoid interferonR Ohno, Y Kodera, M Ogura, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|December 1, 1984
[Treatment of hematological malignancies with recombinant leukocyte A interferon (rIFN-alpha A)]R Ohno, Y Kodera, M Ogura, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|November 1, 1995
[Efficacy of early administration of G-CSF after intensive chemotherapy in acute leukemia: a randomized controlled trial. Tokai Infection Study Group on Hematological Disorders]H Takeyama, H Yamada, N Emi, et al.
International Journal of Hematology|May 1, 1999
CD4- and CD56-positive T-cell line, MTA, established from natural killer-like T-cell leukemia/lymphomaN Emi, A Abe, M Kasai, et al.
Leukemia|February 1, 1995
Establishment and characterization of an immature human megakaryoblastic cell line, MEG-A2A Abe, N Emi, H Kato, et al.
British Journal of Haematology|April 1, 1994
Poor response to intensive chemotherapy in de novo acute myeloid leukaemia with trilineage myelodysplasia. Japan Adult Leukaemia Study Group (JALSG)K Kuriyama, M Tomonaga, T Matsuo, et al.
Leukemia|August 1, 1993
Unexpected heterogeneity of PML/RAR alpha fused mRNA detected by nested polymerase chain reaction in acute promyelocytic leukemiaA Matsuoka, K Miyamura, N Emi, et al.
Chemico-Biological Interactions|February 27, 2016
In vitro antiproliferative activity of 2,3-dihydroxy-9,10-anthraquinone induced apoptosis against COLO320 cells through cytochrome c release caspase mediated pathway with PI3K/AKT and COX-2 inhibitionC Balachandran, N Emi, Y Arun, et al.
Pageof 12